Evidence map›Paper›PMID 26849013›Full record

ArticleBlood cancer journal2016

Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele.

M Sakurai, H Kasahara, K Yoshida, A Yoshimi, H Kunimoto, N Watanabe, Y Shiraishi, K Chiba, H Tanaka, Y Harada and 8 more

Open access · goldAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. GermlineEJHaem · 2023
    Article
  4. Review
  5. Beyond PathogenicCancers · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Hereditary thrombocytopenias: a growing list of disorders.Hematology. American Society of Hematology. Education Program · 2017
    Review
  11. Article
  12. Myeloid neoplasms with germ line RUNX1 mutation.International journal of hematology · 2017
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Frontiers in cell and developmental biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

M SakuraiDivision of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
H KasaharaDivision of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
K YoshidaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
A YoshimiDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
H KunimotoDivision of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
N WatanabeDepartment of Transfusion Medicine & Cell Therapy, Keio University School of Medicine, Tokyo, Japan.
Y ShiraishiLaboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
K ChibaLaboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
H TanakaLaboratory of Sequence Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Y HaradaDepartment of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
H HaradaDepartment of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
T KawakitaDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
M KurokawaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
S MiyanoLaboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
S TakahashiDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
S OgawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
S OkamotoDivision of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
H NakajimaDivision of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
The University of Tokyo · JPKeio University · JPJuntendo University · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesGenetic Predisposition to DiseaseHaploinsufficiencyAdultBlood Platelet DisordersCell Transformation, NeoplasticCore Binding Factor Alpha 2 SubunitFemaleGenetic Association StudiesHumansLeukemia, Myeloid, AcuteMaleMiddle AgedPedigreeCore Binding Factor Alpha 2 Subunit

Identifiers

PMID26849013
PMCPMC4771963
OpenAlexW2271634026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.